
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Pharming Group
Market Cap: €620.2m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€0.88
7D
-20.3%
1Y
-5.4%
Vivoryon Therapeutics
Market Cap: €35.4m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.20
7D
1.3%
1Y
-14.5%